Cargando…

PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.

Detalles Bibliográficos
Autores principales: Mohamed, B., Asma, H., Amina, R., Nadjet, S. A., Zahia, Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429454/
http://dx.doi.org/10.1097/01.HS9.0000851064.99356.34
_version_ 1784779447540383744
author Mohamed, B.
Asma, H.
Amina, R.
Nadjet, S. A.
Zahia, Z.
author_facet Mohamed, B.
Asma, H.
Amina, R.
Nadjet, S. A.
Zahia, Z.
author_sort Mohamed, B.
collection PubMed
description
format Online
Article
Text
id pubmed-9429454
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94294542022-08-31 PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES. Mohamed, B. Asma, H. Amina, R. Nadjet, S. A. Zahia, Z. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429454/ http://dx.doi.org/10.1097/01.HS9.0000851064.99356.34 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Mohamed, B.
Asma, H.
Amina, R.
Nadjet, S. A.
Zahia, Z.
PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.
title PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.
title_full PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.
title_fullStr PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.
title_full_unstemmed PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.
title_short PB2058: IMPACT OF COMORBIDITIES AND RESPONSE TO TREATMENT ON THE MPN SAF ASSESSMENT OF PHILADELPHIA CHROMOSOME NEGATIVE MYELOPROLIFERATIVE SYNDROMES.
title_sort pb2058: impact of comorbidities and response to treatment on the mpn saf assessment of philadelphia chromosome negative myeloproliferative syndromes.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429454/
http://dx.doi.org/10.1097/01.HS9.0000851064.99356.34
work_keys_str_mv AT mohamedb pb2058impactofcomorbiditiesandresponsetotreatmentonthempnsafassessmentofphiladelphiachromosomenegativemyeloproliferativesyndromes
AT asmah pb2058impactofcomorbiditiesandresponsetotreatmentonthempnsafassessmentofphiladelphiachromosomenegativemyeloproliferativesyndromes
AT aminar pb2058impactofcomorbiditiesandresponsetotreatmentonthempnsafassessmentofphiladelphiachromosomenegativemyeloproliferativesyndromes
AT nadjetsa pb2058impactofcomorbiditiesandresponsetotreatmentonthempnsafassessmentofphiladelphiachromosomenegativemyeloproliferativesyndromes
AT zahiaz pb2058impactofcomorbiditiesandresponsetotreatmentonthempnsafassessmentofphiladelphiachromosomenegativemyeloproliferativesyndromes